1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Anti-CD20 Monoclonal Antibodies (MABs) Market 2019 - 2023
- Historic Market Size - Data Table on Global Anti-CD20 Monoclonal Antibodies (MABs) Market 2019 - 2023 ($ million)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
- 5.3 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.5 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
- 5.6 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
- 5.7 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.8 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global anti-CD20 monoclonal antibodies (mABs) market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
- 8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
- 8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 8.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
- 8.4 Neurology - Market size and forecast 2024-2029
- Chart on Neurology - Market size and forecast 2024-2029 ($ million)
- Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
- Chart on Neurology - Year-over-year growth 2024-2029 (%)
- Data Table on Neurology - Year-over-year growth 2024-2029 (%)
- 8.5 Immunology - Market size and forecast 2024-2029
- Chart on Immunology - Market size and forecast 2024-2029 ($ million)
- Data Table on Immunology - Market size and forecast 2024-2029 ($ million)
- Chart on Immunology - Year-over-year growth 2024-2029 (%)
- Data Table on Immunology - Year-over-year growth 2024-2029 (%)
- 8.6 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Type
- 9.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 9.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 9.3 First generation - Market size and forecast 2024-2029
- Chart on First generation - Market size and forecast 2024-2029 ($ million)
- Data Table on First generation - Market size and forecast 2024-2029 ($ million)
- Chart on First generation - Year-over-year growth 2024-2029 (%)
- Data Table on First generation - Year-over-year growth 2024-2029 (%)
- 9.4 Second generation - Market size and forecast 2024-2029
- Chart on Second generation - Market size and forecast 2024-2029 ($ million)
- Data Table on Second generation - Market size and forecast 2024-2029 ($ million)
- Chart on Second generation - Year-over-year growth 2024-2029 (%)
- Data Table on Second generation - Year-over-year growth 2024-2029 (%)
- 9.5 Third generation - Market size and forecast 2024-2029
- Chart on Third generation - Market size and forecast 2024-2029 ($ million)
- Data Table on Third generation - Market size and forecast 2024-2029 ($ million)
- Chart on Third generation - Year-over-year growth 2024-2029 (%)
- Data Table on Third generation - Year-over-year growth 2024-2029 (%)
- 9.6 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 10.3 Hospitals and clinics - Market size and forecast 2024-2029
- Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- 10.4 Academic and research institutions - Market size and forecast 2024-2029
- Chart on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
- Data Table on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
- Chart on Academic and research institutions - Year-over-year growth 2024-2029 (%)
- Data Table on Academic and research institutions - Year-over-year growth 2024-2029 (%)
- 10.5 Contract research organizations - Market size and forecast 2024-2029
- Chart on Contract research organizations - Market size and forecast 2024-2029 ($ million)
- Data Table on Contract research organizations - Market size and forecast 2024-2029 ($ million)
- Chart on Contract research organizations - Year-over-year growth 2024-2029 (%)
- Data Table on Contract research organizations - Year-over-year growth 2024-2029 (%)
- 10.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
11 Market Segmentation by Drug Class
- 11.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
- 11.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- 11.3 Rituximab - Market size and forecast 2024-2029
- Chart on Rituximab - Market size and forecast 2024-2029 ($ million)
- Data Table on Rituximab - Market size and forecast 2024-2029 ($ million)
- Chart on Rituximab - Year-over-year growth 2024-2029 (%)
- Data Table on Rituximab - Year-over-year growth 2024-2029 (%)
- 11.4 Ofatumumab - Market size and forecast 2024-2029
- Chart on Ofatumumab - Market size and forecast 2024-2029 ($ million)
- Data Table on Ofatumumab - Market size and forecast 2024-2029 ($ million)
- Chart on Ofatumumab - Year-over-year growth 2024-2029 (%)
- Data Table on Ofatumumab - Year-over-year growth 2024-2029 (%)
- 11.5 Obinutuzumab - Market size and forecast 2024-2029
- Chart on Obinutuzumab - Market size and forecast 2024-2029 ($ million)
- Data Table on Obinutuzumab - Market size and forecast 2024-2029 ($ million)
- Chart on Obinutuzumab - Year-over-year growth 2024-2029 (%)
- Data Table on Obinutuzumab - Year-over-year growth 2024-2029 (%)
- 11.6 Ublituximab - Market size and forecast 2024-2029
- Chart on Ublituximab - Market size and forecast 2024-2029 ($ million)
- Data Table on Ublituximab - Market size and forecast 2024-2029 ($ million)
- Chart on Ublituximab - Year-over-year growth 2024-2029 (%)
- Data Table on Ublituximab - Year-over-year growth 2024-2029 (%)
- 11.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 11.8 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
12 Market Segmentation by Route of Administration
- 12.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
- 12.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 12.3 Intravenous - Market size and forecast 2024-2029
- Chart on Intravenous - Market size and forecast 2024-2029 ($ million)
- Data Table on Intravenous - Market size and forecast 2024-2029 ($ million)
- Chart on Intravenous - Year-over-year growth 2024-2029 (%)
- Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
- 12.4 Subcutaneous - Market size and forecast 2024-2029
- Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
- Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
- Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
- Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
- 12.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
13 Customer Landscape
- 13.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
14 Geographic Landscape
- 14.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 14.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 14.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 14.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 14.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 14.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 14.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 14.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 14.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 14.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 14.11 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 14.12 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 14.13 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 14.14 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 14.15 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 14.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 14.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
15 Drivers, Challenges, and Opportunity/Restraints
- 15.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 15.4 Market opportunities/restraints
16 Competitive Landscape
- 16.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 16.3 Landscape disruption
- Overview on factors of disruption
- 16.4 Industry risks
- Impact of key risks on business
17 Competitive Analysis
- 17.2 Company ranking index
- 17.3 Market positioning of companies
- Matrix on companies position and classification
- 17.4 Acrotech Biopharma Inc.
- Acrotech Biopharma Inc. - Overview
- Acrotech Biopharma Inc. - Product / Service
- Acrotech Biopharma Inc. - Key offerings
- SWOT
- 17.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- 17.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- 17.7 Celltrion Healthcare Co. Ltd.
- Celltrion Healthcare Co. Ltd. - Overview
- Celltrion Healthcare Co. Ltd. - Business segments
- Celltrion Healthcare Co. Ltd. - Key offerings
- Celltrion Healthcare Co. Ltd. - Segment focus
- SWOT
- 17.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 17.9 Fosun International Ltd.
- Fosun International Ltd. - Overview
- Fosun International Ltd. - Business segments
- Fosun International Ltd. - Key offerings
- Fosun International Ltd. - Segment focus
- SWOT
- 17.10 Genmab AS
- Genmab AS - Overview
- Genmab AS - Product / Service
- Genmab AS - Key offerings
- SWOT
- 17.11 IGM Biosciences Inc.
- IGM Biosciences Inc. - Overview
- IGM Biosciences Inc. - Product / Service
- IGM Biosciences Inc. - Key offerings
- SWOT
- 17.12 JSC BIOCAD
- JSC BIOCAD - Overview
- JSC BIOCAD - Product / Service
- JSC BIOCAD - Key offerings
- SWOT
- 17.13 LFB SA
- LFB SA - Overview
- LFB SA - Product / Service
- LFB SA - Key offerings
- SWOT
- 17.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 17.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 17.16 Regeneron Pharmaceuticals Inc.
- Regeneron Pharmaceuticals Inc. - Overview
- Regeneron Pharmaceuticals Inc. - Product / Service
- Regeneron Pharmaceuticals Inc. - Key offerings
- SWOT
- 17.17 Spectrum Pharmaceuticals Inc.
- Spectrum Pharmaceuticals Inc. - Overview
- Spectrum Pharmaceuticals Inc. - Product / Service
- Spectrum Pharmaceuticals Inc. - Key offerings
- SWOT
- 17.18 TG Therapeutics Inc.
- TG Therapeutics Inc. - Overview
- TG Therapeutics Inc. - Product / Service
- TG Therapeutics Inc. - Key offerings
- SWOT
18 Appendix
- 18.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 18.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 18.4 Research methodology
- 18.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 18.9 360 degree market analysis
- 360 degree market analysis
- 18.10 List of abbreviations
Get the report (PDF) sent to your email within minutes.